Equities

Applied DNA Sciences Inc

Applied DNA Sciences Inc

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (USD)1.25
  • Today's Change0.035 / 2.89%
  • Shares traded645.68k
  • 1 Year change-95.10%
  • Beta0.3709
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

  • Revenue in USD (TTM)3.40m
  • Net income in USD-7.52m
  • Incorporated2008
  • Employees53.00
  • Location
    Applied DNA Sciences Inc50 Health Sciences DriveSTONY BROOK 11790United StatesUSA
  • Phone+1 (631) 240-8800
  • Fax+1 (631) 240-8900
  • Websitehttps://adnas.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ALR Technologies Inc9.49k-8.00m10.17m6.00------1,071.39-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Bionoid Pharma Inc0.001.35m10.80m13.000.1764--7.98--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
PetVivo Holdings Inc975.28k-10.11m10.86m20.00--13.03--11.14-0.6705-0.67050.0620.04170.32570.40516.3748,764.00-337.63-230.77-589.09-467.9983.6066.21-1,036.50-1,501.440.455-1,075.050.0221--5.62---25.67--23.91--
Vivos Therapeutics Inc14.02m-12.05m10.95m114.00--1.73--0.7811-6.98-6.986.881.870.9477--38.84123,000.00-81.41-89.72-166.05-149.7060.0870.20-85.90-113.15----0.00---13.8729.4843.04---8.48--
Scientific Industries Inc10.45m-7.76m12.29m63.00--1.05--1.18-0.9231-0.92311.171.110.73431.139.08165,942.90-54.50---62.11--45.41---74.22--3.15--0.00--------------
STRATA Skin Sciences Inc32.73m-8.31m12.35m99.00--1.09--0.3772-2.37-2.379.352.710.69063.477.81330,606.10-17.54-11.48-24.26-16.5554.3061.28-25.40-17.700.9176-2.690.6141---7.752.24-95.17--23.29--
Dalrada Financial Corporation32.16m-21.34m12.41m0.00--1.41--0.386-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Applied DNA Sciences Inc3.40m-7.52m12.46m53.00--1.01--3.67-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
QT Imaging Holdings Inc0.00-4.02m12.86m----0.5917-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
REMSleep Holdings Inc144.88k-1.81m14.41m6.00--25.06--99.46-0.0012-0.00120.00010.00040.081.694.75---99.82-152.40-122.32-317.98-491.08---1,246.94-2,317.521.47-43.580.1207---36.48--12.13--28.26--
Trinity Biotech plc (ADR)58.65m-22.29m14.55m380.00------0.2482-2.74-2.747.23-19.240.70521.693.74154,347.40-26.80-20.30-35.44-29.5434.2839.92-38.01-29.860.8936-2.161.46---9.10-10.1515.41---31.08--
Autonomix Medical Inc-100.00bn-100.00bn15.01m5.00--2.37----------0.2749----------------------------0.1647-------674.99------
LiveCare Inc0.00-2.34m15.26m----6.47-----0.1411-0.14110.000.04630.00-------424.83---550.62-------------8.180.1888-------344.86------
Cutera Inc169.19m-148.97m15.50m430.00------0.0916-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
Innovative Eyewear Inc1.53m-7.86m15.53m11.00--2.06--10.15-11.01-11.012.054.810.17791.9715.91139,070.90-91.45---96.06---2.46---514.10--12.85--0.00--74.67---17.28------
Data as of Sep 20 2024. Currency figures normalised to Applied DNA Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

4.18%Per cent of shares held by top holders
HolderShares% Held
S.H.N. Financial Investments Ltd.as of 28 May 2024108.00k1.05%
L1 Capital Global, Inc.as of 01 Aug 2024108.00k1.05%
Altium Capital Management LPas of 30 Jun 202486.15k0.84%
Sabby Management LLCas of 30 Jun 202470.46k0.68%
Virtu Americas LLCas of 30 Jun 202419.02k0.19%
Ground Swell Capital LLCas of 30 Jun 202415.25k0.15%
XTX Markets LLCas of 30 Jun 202410.26k0.10%
BlackRock Fund Advisorsas of 30 Jun 20245.07k0.05%
Tower Research Capital LLCas of 30 Jun 20244.07k0.04%
Morgan Stanley & Co. LLCas of 30 Jun 20243.94k0.04%
More ▼
Data from 30 Jun 2024 - 29 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.